Acts of Parliament assented to – Act Nos 39 to 44 of 2025

Overview

The National Health Amendment (Cheaper Medicines) Act 2025 was enacted to address the rising costs of prescription medicines for Australians, a significant issue impacting affordability and access to necessary healthcare. By amending the National Health Act 1953, the Act aims to introduce measures that will reduce the financial burden of prescription drugs on individuals and the broader healthcare system. The policy objective is to ensure that essential medications remain accessible and affordable for all Australians, thereby improving health outcomes and reducing the economic strain on consumers. This Act was passed by the Parliament of Australia, reflecting the legislature's commitment to enhancing the health and wellbeing of the population through strategic legislative amendments.

Scope and Application

The National Health Amendment (Cheaper Medicines) Act 2025 applies to individuals and entities involved in the healthcare sector, including pharmaceutical companies, healthcare providers, and consumers, with a focus on the pricing and availability of medicines. This Act aims to amend the National Health Act 1953, thereby extending its application across the Commonwealth to ensure that Australians have access to affordable and necessary medications. The Act does not explicitly state any exclusions or exemptions, though it may be subject to further clarification through subordinate legislation or regulations. The scope of this amendment is intended to improve the affordability and accessibility of medicines, impacting various stakeholders within the healthcare industry. The Act’s geographic reach is national, applying uniformly across Australia to ensure consistent standards and practices in the provision and pricing of medicines. The Home Affairs Legislation Amendment (2025 Measures No. 1) Act 2025 pertains to the Department of Home Affairs and encompasses the regulation of migration and related activities. This Act applies to individuals, entities, and entities involved in immigration services, including visa applicants, immigration officers, and service providers. It seeks to amend existing migration laws to implement new measures aimed at streamlining processes and enhancing the efficiency of the immigration system. The Act’s jurisdiction is nationwide, applying to all states and territories within Australia, thereby ensuring uniformity in the administration of migration laws. While the Act does not explicitly outline exclusions or exemptions, it is expected that further detail will be provided through subordinate instruments. This legislation is part of broader efforts to refine and modernise Australia’s immigration framework, affecting a wide range of participants within the migration ecosystem.

Key Provisions

The National Health Amendment (Cheaper Medicines) Act 2025 (section 3(1)) introduces measures to ensure that prescription medicines are more affordable for Australians. This Act amends the National Health Act 1953 by introducing provisions that require the Pharmaceutical Benefits Scheme (PBS) to negotiate lower prices for prescription medicines with pharmaceutical companies. The Act also mandates that the government provide additional subsidies to help reduce the out-of-pocket costs for patients, especially for those on low incomes or with chronic conditions. The primary aim is to make essential medications more accessible and affordable without compromising on quality or safety. Under the new provisions, pharmaceutical companies are required to enter into negotiations with the government to reach agreed prices for medicines listed on the PBS (section 5(2)). Companies that fail to comply with these negotiations may face penalties, including exclusion from the PBS list, which could significantly impact their market access in Australia. Furthermore, the Act imposes an obligation on the government to review and adjust the PBS list regularly to ensure that the most cost-effective medicines are included (section 6(1)). This ongoing review process aims to maintain the balance between affordability and the availability of necessary treatments. The Health Insurance (Pathology) (Fees) (Repeal) Act 2025 (section 2(1)) repeals the Health Insurance (Pathology) (Fees) Act 1991 and removes the statutory fee schedule for pathology services. This change is intended to allow for more flexible fee arrangements between healthcare providers and insurers, potentially leading to cost savings that could be passed on to consumers. By removing the fixed fee schedule, the Act seeks to foster competition and innovation in the pathology sector, which could result in better services and more competitive pricing. The Australian Security Intelligence Organisation Amendment Act (No. 1) 2025 (section 4(3)) revises the powers and functions of the Australian Security Intelligence Organisation (ASIO). This Act grants ASIO additional authority to conduct investigations into activities that may pose a threat to national security, including cyber-attacks and foreign interference. It also enhances the agency's ability to share information with other law enforcement and intelligence agencies both domestically and internationally. These expanded powers are designed to better protect Australia's national security interests in an increasingly complex and interconnected world. The Home Affairs Legislation Amendment (2025 Measures No. 1) Act 2025 (section 7(1)) makes significant changes to Australia's migration laws. It introduces stricter visa application processes and more rigorous background checks for applicants. This Act aims to enhance the integrity of the immigration system and prevent illegal immigration and related crimes. It also imposes new obligations on employers to verify the immigration status of their employees, with penalties for non-compliance. These measures are intended to ensure that only those who meet the necessary criteria are granted visas and that the workforce remains compliant with immigration laws. The Aged Care (Accommodation Payment Security) Levy Amendment Act 2025 (section 8(2)) modifies the Aged Care (Accommodation Payment Security) Levy Act 2006 by increasing the levy on aged care providers to improve financial stability and service quality. This Act ensures that providers have adequate funds to meet their obligations to residents, particularly in the event of financial difficulties. It also includes provisions for better oversight and accountability, requiring providers to submit regular financial reports to the government. The Pacific Banking Guarantee Act 2025 (section 9(1)) authorises the government to provide financial guarantees for banking institutions operating in the Pacific region. This Act aims to support economic stability and financial inclusion in Pacific countries by ensuring that local banks have access to necessary capital. The government's role in providing these guarantees is intended to foster trust in the banking system and encourage investment in the region. The Act also outlines the conditions under which these guarantees will be provided and the mechanisms for monitoring and reviewing their use.